Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Summary

The goal of this clinical research study is to learn if Tarceva ® (erlotinib) when taken before and after radiation and/or surgery can help to control aggressive cutaneous squamous cell carcinoma. The safety of the drug will also be studied.

Timeline

Start

2011-02

Primary completion

2016-03

Completion

2016-03

Outcome

Outcome not reported

Stopped: “Lack of primary outcome efficacy.”

Drugs

Indications